Fyodor, your critique matters. And so does the research to show the boundaries. In addition to promise, we show potential for base editor toxicity in human embryos: clearly not a green light. As you know, my lab did the same for Cas9 when a claim was published that it could correct a mutation, but instead removed chromosomes. Great promise without documented risk enables the very thing we want to prevent: a premature and uninformed run to the clinic. We saw it with Cas9. Thats why we do this work: data first. Thank you for the discussion.
.
@carlzimmer clearly sums up data and impact of another foray of gene editing into human embryos. I thank Carl for the opportunity to say: the data are ho-hum.
The impact? "Baby improvers" worldwide will read and cheer and put to use.
Be afraid. I am.
nytimes.com/2026/06/04/scien…